Cited by 391SARS-CoV-2 and COVID-19 Researchinterferon and immune responsesCOVID-19 Clinical Research Studies

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Human immunopathogenesis of severe acute respiratory syndrome (SARS)

Open access

Cameron, Mark J., Bermejo-Martin, Jesus F., Danesh, Ali, Muller, Matthew P., Kelvin, David J.·2008·Virus Research

DOI 10.1016/j.virusres.2007.02.014PMC PMC7114310

Open this paper in CoChat — free account

Abstract

Progressive immune-associated injury is a hallmark of severe acute respiratory syndrome (SARS). Viral evasion of innate immunity, hypercytokinemia and systemic immunopathology in the SARS coronavirus (SARS CoV) infected host have been suggested as possible mechanisms for the cause of severe pathology and morbidity in SARS patients. The molecular and cellular basis for how SARS CoV impacts the host immune system resulting in severe SARS, however, has not been elucidated. The variable clinical course of SARS may be the result of complex programs of host responses against the infectious agent. Therefore, the systematic analysis of innate and adaptive immune responses to SARS CoV is imperative in building as complete an immunological model as possible of host immunity and inflammatory responses during illness. Here we review recent advances in SARS immunopathogenesis research and present a summary of our findings regarding host responses in SARS patients. We contend that dysregulated type I and II interferon (IFN) responses during SARS may culminate in a failure of the switch from hyper-innate immunity to protective adaptive immune responses in the human host.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.virusres.2007.02.014

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N. L. S., Hui, D. S. C., Wu, A. K. L., Chan, P. K. S., Cameron, P. A., Joynt, G. M., Ahuja, A. T., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,638
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
Booth, C. M. (2003) · JAMA · doi:10.1001/jama.289.21.joc30885 · Cited by 1,405
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
Wong, C. K., LAM, C. W. K., Wu, A. K. L., Ip, W., Lee, N. L. S., Chan, I., Lit, L. C. W., Hui, D. S. C., Chan, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,270
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217
Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways
Ding, Y., He, L., Zhang, Q., Huang, Z., Che, X., Hou, J., Wang, H., Shen, H., Qiu, L., Li, Z., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1560 · Cited by 1,082
Lung pathology of fatal severe acute respiratory syndrome
Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M., Hui, P. K., Mak, K. L., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13413-7 · Cited by 1,076

Flagged first, then by citations

Show all 39 references

Sorted by citations

Items 201–300 of 386

Chloroquine and Hydroxychloroquine
Barber, B. E. (2017) · doi:10.1201/9781498747967-175 · Cited by 15
Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics
Saleemi, M. A., Ahmad, B., Benchoula, K., Vohra, M. S., Mea, H. J., Chong, P. P., Palanisamy, N. K., & Wong, E. H. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104583 · Cited by 16
Myocardial injury in severe and critical coronavirus disease 2019 patients
Guo, H., Shen, Y., Wu, N., & Sun, X. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.15164 · Cited by 15
The Systemic Inflammation Index on admission is independently associated with length of stay in hospitalized COVID-19 patients
Zinellu, A., Scano, V., MASOTTO, E., RIU, G. D., Vaira, L. A., Carru, C., Pirina, P., Babudieri, S., Mangoni, A. A., & Fois, A. G. (2021) · Minerva Respiratory Medicine · doi:10.23736/s2784-8477.21.01932-5 · Cited by 15
Traditional Chinese Medicine Diagnosis “Yang-Xu Zheng”: Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock
Lin, J., Cheng, Y.-Y., Chang, C., Lee, C.-H., Huang, Y.-C., & Su, Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/759748 · Cited by 15
An Introduction to SARS Coronavirus 2; Comparative Analysis with MERS and SARS Coronaviruses: A Brief Review
Taherizadeh, M., Tabibzadeh, A., Panahi, M., Tameshkel, F. S., Golahdooz, M., & Niya, M. H. K. (2020) · Iranian Journal of Public Health · doi:10.18502/ijph.v49is1.3667 · Cited by 15
Antiviral properties of placental growth factors: A novel therapeutic approach for COVID-19 treatment
Joshi, M. G., Kshersagar, J. R., Desai, S. R., & Sharma, S. R. (2020) · Placenta · doi:10.1016/j.placenta.2020.07.033 · Cited by 15
Arritmias Cardíacas em Pacientes com COVID-19
Pimentel, M., Magalhães, A. P. A., Novak, C. V., May, B. M., da Rosa, L. G. B., & Zimerman, L. I. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200963 · Cited by 14
Complement inhibition: A possible therapeutic approach in the fight against Covid‐19
Deravi, N., Ahsan, E., Fathi, M., Hosseini, P., Yaghoobpoor, S., Lotfi, R., Pourbagheri‐Sigaroodi, A., & Bashash, D. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2316 · Cited by 14
Anxiety, Depression, and Sleep Disorders After COVID-19 Infection
Yıldızeli, Ş. O., Kocakaya, D., Saylan, Y. H., Taştekin, G., Yıldız, S., Akbal, Ş., Özkan, S., Arıkan, H., & Karakurt, S. (2023) · Cureus · doi:10.7759/cureus.42637 · Cited by 14
The transmission dynamics of Middle East Respiratory Syndrome coronavirus
Rui, J., Wang, Q., Lv, J., Zhao, B., Hu, Q., Du, H., Gong, W., Zhao, Z., Xu, J., Zhu, Y., et al. (2021) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2021.102243 · Cited by 14
The unique ORF8 protein from SARS-CoV-2 binds to human dendritic cells and induces a hyper-inflammatory cytokine storm
Hamdorf, M., Imhof, T., Bailey-Elkin, B. A., Betz, J., Theobald, S. J., Simonis, A., Cristanziano, V. D., Gieselmann, L., Dewald, F., Lehmann, C., et al. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad062 · Cited by 16
Monitoring Air Quality and Estimation of Personal Exposure to Particulate Matter Using an Indoor Model and Artificial Neural Network
Oh, J. H., & Kim, J. (2020) · Sustainability · doi:10.3390/su12093794 · Cited by 14
Risk of coronavirus disease 2019 (COVID-19) infection on leukemia patients: basic science to clinical aspect
Sumantri, A. F., Bashari, M. H., Tadjoedin, H., & Atik, N. (2022) · Journal Of Advanced Pharmacy Education And Research · doi:10.51847/qqiktbahb7 · Cited by 13
Curcumin as an antiviral agent and immune-inflammatory modulator in COVID-19: A scientometric analysis
Liu, K., Zhu, Y., Cao, X., Liu, Y., Ying, R., Huang, Q., Gao, P., & Zhang, C. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21648 · Cited by 13
Perspective of molecular immune response of SARS-COV-2 infection
Rohmah, M. K., & Nurdianto, A. R. (2020) · Jurnal Teknologi Laboratorium · doi:10.29238/teknolabjournal.v9i1.218 · Cited by 13
Coronavirus and its terrifying inning around the globe: The pharmaceutical cares at the main frontline
Ullah, M., Wahab, A., Saeed, S., Khan, S. U., Ali, H., Humayun, S., Abbasi, B. A., Saud, S., Naveed, K., Khan, S. A., et al. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.129968 · Cited by 14
Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection
Bahari, Z., Jangravi, Z., Ghoshooni, H., Afarinesh, M. R., & Meftahi, G. H. (2021) · Inflammation Research · doi:10.1007/s00011-021-01445-2 · Cited by 13
First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1
de Castro, I., Guzmán, M. G., García–Álvarez, M., & Resino, S. (2010) · Critical Care · doi:10.1186/cc8846 · Cited by 12
Outcomes of intravenous immunoglobulin treatment of immunocompromised patients with viral respiratory infections
Moughames, E., Sakayan, S., Prichett, L. M., Runken, M. C., Borst, D., Tversky, J. R., & Azar, A. (2024) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2024.09.001 · Cited by 11
The type I interferon response during viral infections: a “SWOT” analysis
Gaajetaan, G. R., Bruggeman, C. A., & Stassen, F. R. M. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.713 · Cited by 12
COVID-19 and SARS-CoV-2: Everything we know so far – A comprehensive review
Naz, S., Zahoor, M., Sahibzada, M. U. K., Ullah, R., & Alqahtani, A. S. (2021) · Open Chemistry · doi:10.1515/chem-2021-0049 · Cited by 14
Physical and mental health impact of the COVID-19 pandemic at first year in a Spanish adult cohort
Castellví, P., Miranda-Mendizábal, A., Recoder, S., Calbo, E., Casajuana‐Closas, M., Leiva, D., Manolov, R., Santander, N. M., Lloveras-Bernat, I., & Forero, C. G. (2023) · Scientific Reports · doi:10.1038/s41598-023-28336-2 · Cited by 11
An update on emerging therapeutics to combat COVID‐19
Shah, N. N., Nabi, S. U., Rather, M. A., Kalwar, Q., Ali, S. I., Sheikh, W. M., Ganai, A., & Bashir, S. M. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13600 · Cited by 10
Vaccine efficacy in mutant SARS-CoV-2 variants.
Kandikattu, H. K., Yadavalli, C. S., Venkateshaiah, S. U., & Mishra, A. (2021) · PubMed · doi:10.264195/ijcbp.isp · Cited by 10
Comparative Pathogenesis of Severe Acute Respiratory Syndrome Coronaviruses
Zhang, J., Rissmann, M., Kuiken, T., & Haagmans, B. L. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052620-121224 · Cited by 10
Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19)
Dong, X., Wang, M., Liu, S., Zhu, J., Xu, Y., Cao, H., & Li, L. (2020) · Aging and Disease · doi:10.14336/ad.2020.0317 · Cited by 10
Low-dose radiotherapy for COVID 19
Kumar, R., Haresh, K., Sharma, D., Gupta, A. K., Gupta, S., Subramani, V., & Rath, G. (2021) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1045_20 · Cited by 10
Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 Pandemic
Weber, M. S., Nicholas, J. A., & Yeaman, M. R. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001067 · Cited by 12
Role of cytokine storm in coronavirus infections: culprit or accomplice?
Xu, R., Liu, C., Xu, X., Hu, Y., Zhu, B., & Yang, C. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2703102 · Cited by 10
Rapid Survey of Psychological Status of Health-Care Workers during the Early Outbreak of COVID-19 Pandemic
Kumar, R., Das, A., Singh, V., Gupta, P. K., & Bahurupi, Y. A. (2021) · Journal of Medical Evidence · doi:10.4103/jme.jme_8_21 · Cited by 10
Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19
Yang, S., Tong, Y., Chen, L., & Yu, W. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00077-0 · Cited by 10
SARS-CoV-2 specific adaptations in N protein inhibit NF-κB activation and alter pathogenesis
Guo, X. F., Yang, S., Cai, Z., Zhu, S., Wang, H., Liu, Q., Zhang, Z., Feng, J., Chen, X., Li, Y., et al. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202404131 · Cited by 9
Predictors of critical illness and mortality based on symptoms and initial physical examination for patients with SARS-CoV-2: A retrospective cohort study
Bairwa, M. C., Kumar, R., Ajmal, M., Bahurupi, Y. A., & Kant, R. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.06.010 · Cited by 9
Severe Acute Respiratory Syndrome Coronavirus Elicits a Weak Interferon Response Compared to Traditional Interferon-Inducing Viruses
Scagnolari, C., Trombetti, S., Cicetti, S., Antonelli, S., Selvaggi, C., Perrone, L., Visca, M., Romano, S., & Antonelli, G. (2008) · Intervirology · doi:10.1159/000154258 · Cited by 9
Severe acute respiratory syndrome coronavirus 2 for physicians: Molecular characteristics and host immunity (Review)
Shang, J., Du, L., Han, N., Lv, D., Wang, J., Yang, H., Bai, L., & Tang, H. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11901 · Cited by 9
Origin, Pathogenesis, Diagnosis and Treatment Options for SARS-CoV-2: A Review
Sajjad, H., Majeed, M., Imtiaz, S., Siddiqah, M., Sajjad, A., Din, M., & Ali, M. (2021) · Biologia · doi:10.1007/s11756-021-00792-z · Cited by 8
Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions
Sharma, A. K., Sharma, V., Arun, S., Pallikkuth, S., & Sharma, A. K. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200711153829 · Cited by 11
Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19
Yang, A., Guduguntla, L., & Yang, B. X. (2020) · Journal of Cellular Immunology · doi:10.33696/immunology.2.063 · Cited by 9
Mechanism involved in the pathogenesis and immune response against SARS-CoV-2 infection
Sahu, U., Biswas, D., Singh, A. K., & Khare, P. S. (2021) · VirusDisease · doi:10.1007/s13337-021-00687-2 · Cited by 8
Post-COVID depression among a sample of Egyptian patients and its associated factors
Ezzelregal, H. G., Hassan, A. M., Mohamed, R. S., & Ahmed, N. (2021) · Egyptian Journal of Bronchology · doi:10.1186/s43168-021-00086-7 · Cited by 8
Role of the cellular immunity in the formation of the immune response in coronavirus infections
Ia, I., Omelchenko, N. D., Filippenko, A. V., Trufanova, A. A., & Носков, А. К. (2021) · Medical Immunology (Russia) · doi:10.15789/1563-0625-rot-2302 · Cited by 11
Analysis of differential gene expression of pro-inflammatory cytokines in the nasopharyngeal milieu of mild & severe COVID-19 cases
Ghulam, U., Nazim, F., Farooqui, N., Rizwan-ul-Hasan, S., Anwar, M. F., Ahmed, K., Jamal, A., Kayani, H. A., Mughal, N., Hussain, A. R., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0279270 · Cited by 7
TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower inflammatory consequences
Govednik, T., Lainšček, D., Kuhar, U., Lachish, M., Janežič, S., Štrbenc, M., Krapež, U., Jerala, R., Atlas, D., & Manček‐Keber, M. (2024) · Antiviral Research · doi:10.1016/j.antiviral.2024.105806 · Cited by 7
Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond
Beecker, J. R., Papp, K. A., Dutz, J. P., Vender, R. B., Gniadecki, R., Cooper, C., Gisondi, P., Gooderham, M., Hong, C. H., Kirchhof, M. G., et al. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17075 · Cited by 7
Molecular and Clinical Investigation of COVID-19: From Pathogenesis and Immune Responses to Novel Diagnosis and Treatment
Kashani, N. R., Azadbakht, J., Ehteram, H., Kashani, H. H., Moghadam, H. R., Ahmad, E., Nikzad, H., & Hosseini, E. S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.770775 · Cited by 7
Evaluation of 34 Cytokines and Vitamin D Status Reveal A Sexually-Dimorphic Active Immune Response to SARS-CoV-2
Amer, O. E., Sabico, S., Sheshah, E., Alotaibi, N. H., Aldisi, D. A., Enani, M. A., Aljohani, N. J., Alshingetti, N. M., Alomar, S. Y., Hussain, S. D., et al. (2022) · Healthcare · doi:10.3390/healthcare10122571 · Cited by 7
COVID-19 handling report for pre-case, case (pre-hospital and hospital), and post-case phases in the elderly as vulnerable populations in 6 Asia Pacific countries
Susilowati, I. H., Nakatani, H., Nugraha, S., Pengpid, S., Keawpan, W., Hasiholan, B. P., Toai, N. P., Abdeali, A., Isahak, M., & Kamso, S. (2020) · Global Health & Medicine · doi:10.35772/ghm.2020.01061 · Cited by 7
Inhaled interferons beta and SARS-COV2 infection: a preliminary therapeutic perspective
Cojocaru, E., Cojocaru, C., Antoniu, S. A., Stafie, C. S., Râjnoveanu, A. G., & Râjnoveanu, R. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2008910 · Cited by 7
Advanced biomaterials for regenerative medicine and their possible therapeutic significance in treating COVID-19: a critical overview
Sarangi, A. K., Salem, M. A., Younus, M. D., El-Haroun, H., Mahal, A., Tripathy, L., Mishra, R., Shabil, M., Alhumaydhi, F. A., Khatib, M. N., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000002110 · Cited by 9
Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics
Chavda, V. P., Raval, N., Sheta, S., Vora, L. K., Elrashdy, F., Redwan, E. M. M. M., Uversky, V. N., & Ertaş, Y. N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1064459 · Cited by 6
COVID‐19 and hydatidiform mole
Abbas, A. M., Ahmed, L., Salem, A. S., Elsamman, S. H., Refai, A., Fathy, S. K., Ahmed, O., Shalotut, A. S., & AbdelWahab, R. A. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13310 · Cited by 5
A Recent Update on SARS-CoV-2 Transmission and its Variants: Transmission, Pathogenic Mechanism, and Treatment
Singh, V., Jain, S. K., & Mishra, V. (2023) · Coronaviruses · doi:10.2174/2666796704666230102121225 · Cited by 5
Paradigm of immune dysregulation in coronavirus disease-2019 infection
Sahoo, O. S., Pethusamy, K., Nayek, A., Minocha, R., Dhar, R., & Karmakar, S. (2024) · Exploration of Immunology · doi:10.37349/ei.2024.00126 · Cited by 7
Can mesenchymal stem cells be used to treat COVID‑19‑induced pneumonia? (Review)
Çeti̇n, İ., & Topçul, M. (2020) · Biomedical Reports · doi:10.3892/br.2020.1369 · Cited by 5
Inflammatory pathways and potential therapies for COVID-19: A mini review
Dabbish, A. M., Yonis, N., Salama, M., Essa, M. M., & Qoronfleh, M. W. (2021) · European Journal of Inflammation · doi:10.1177/20587392211002986 · Cited by 5
Genomic and biological variation in bat IFNs: An antiviral treatment approach
AL-Eitan, L. N., Mihyar, A. H., Zhang, L., Bisht, P., & Jaenisch, R. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2488 · Cited by 6
Albendazole Reduces Serum Levels of Inflammatory Cytokines: Potential Strategy for the Management of Cytokine Storm
Onifade, A. A., & Arinola, G. O. (2020) · Saudi Journal of Biomedical Research · doi:10.36348/sjbr.2020.v05i11.006 · Cited by 5
SARS-CoV-2: Insights from the Immunopathogenesis and Current Clinical Diagnosis and Therapeutic Strategies
Sharma, S., Sharma, U., Chaudhary, A., Naithani, M., Naithani, P., Prashar, S., Sharma, B., Nagar, P. K., Bhukya, P. L., halerao, U. B., et al. (2021) · Journal of Immunological Sciences · doi:10.29245/2578-3009/2021/2.1207 · Cited by 5
Low CD4 T cell count predicts radiological progression in severe and critically ill COVID-19 patients: a case control study
Wang, Q., Yao, Y., Huang, Z., Cao, J., Zhu, C., Yu, K., Pan, J., & Hu, B. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-20-1848 · Cited by 5
Molecular mechanisms and signaling pathways involved in immunopathological events of COVID-19
Peyvandi, A. A., Niknazar, S., Mehrjerdi, F. Z., Abbaszadeh, H., Khoshsirat, S., & Peyvandi, M. (2021) · Physiology and Pharmacology · doi:10.52547/ppj.25.3.193 · Cited by 5
Iran may become the center of challenges in Middle East for outbreak of delta variant-COVID-19
(2021) · Iranian Red Crescent Medical Journal · doi:10.32592/ircmj.2021.23.11.1394 · Cited by 5
COVID-19: Targeting the cytokine storm via cholinergic anti-inflammatory (Pyridostigmine)
Osman Ahmed, H. (2020) · International Journal of Clinical Virology · doi:10.29328/journal.ijcv.1001014 · Cited by 4
SARS-CoV-2 Recombinant Spike Protein-based Vaccine: A Promising Candidate against the Recent Imperial Coronavirus Disease (COVID-19)
Chukwuemeka, P. O., Olowosoke, C. B., & Oretade, O. M. (2020) · International Journal of Pathogen Research · doi:10.9734/ijpr/2020/v4i330115 · Cited by 4
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Codon Usage and Replicative Fitness
Kanduc, D. (2020) · Global Medical Genetics · doi:10.1055/s-0040-1721080 · Cited by 4
Journey so far with COVID 19 – a comprehensive review
Roy, S. (2021) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2020.4.7 · Cited by 4
Virology of SARS-CoV-2 and management of nCOVID-19 utilizing immunomodulation properties of human mesenchymal stem cells—a literature review
Sachdeva, K., Kumar, A., & Mohanty, S. (2021) · Stem Cell Investigation · doi:10.21037/sci-2020-040 · Cited by 3
ADOPSI DAN IMPLEMENTASI KECAKAPAN LITERASI INFORMASI DAN LITERASI DIGITAL UNTUK AKSELERASI UMKM DI INDONESIA PASCA PANDEMI COVID-19
Putra, P., Windah, A., & Tarisa, A. (2022) · Fihris Jurnal Ilmu Perpustakaan dan Informasi · doi:10.14421/fhrs.2021.162.177-199 · Cited by 4
Leukotriene inhibitors with dexamethasone show promise in the prevention of death in COVID-19 patients with low oxygen saturations
Elkin, P. L., Resendez, S. D., Mullin, S., Troen, B. R., Mammen, M. J., Chang, S. S., Franklin, G., McCray, W., & Brown, S. H. (2022) · Journal of Clinical and Translational Science · doi:10.1017/cts.2022.401 · Cited by 4
Coronavirus disease 2019 and the cardiologist
Mohammad, K. O., Rodriguez, J. B. C., & Urey, M. A. (2022) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000958 · Cited by 4
Associations of the neutrophil/lymphocyte ratio, monocyte/ lymphocyte ratio, and platelet/lymphocyte ratio with COVID-19 disease severity in patients with neurological symptoms: A cross-sectional monocentric study
Şahin, B. E., Çelikbilek, A., Koçak, Y., Köysüren, A., & Hızmalı, L. (2022) · Journal of Neurosciences in Rural Practice · doi:10.25259/jnrp_6_2022 · Cited by 4
Psychiatric Symptoms and Fatigue in COVID-19 Survivors
Naphade, P. U., Singh, P., Rao, P., Rohatgi, S. J., Chaudhury, S., Jadhav, S. L., & Nirhale, S. P. (2023) · Cureus · doi:10.7759/cureus.45651 · Cited by 4
COVID-19: Between Past and Present
Assaf, A. M., Haddadin, R. N., & Akour, A. A. (2020) · Viral Immunology · doi:10.1089/vim.2020.0102 · Cited by 4
COVID-19: A Devastating Pandemic
Kumar, P., Ahmad, M. I., & Singh, S. (2020) · Pharmaceutical Sciences · doi:10.34172/ps.2020.34 · Cited by 4
COVID-19: Epidemiology, Pathogenesis and Immununological Basis
de, E. S. D. T. B. E. A. (. D. M. E., & Nguepou, C. T. (2020) · Journal of Al-Nahrain University-Science · doi:10.22401/anjs.00.4.01 · Cited by 4
Obésité, inflammation et COVID-19 : intérêt préventif de l’alimentation cétogène ?
Charlot, A., Boumiza, R., Roux, M., & Zoll, J. (2021) · Biologie Aujourd hui · doi:10.1051/jbio/2021004 · Cited by 4
Review on Potential Herbal Remedies to Combat Covid-19
Jikadara, J., & Roy, S. P. (2021) · Journal of Ayurvedic and Herbal Medicine · doi:10.31254/jahm.2021.7211 · Cited by 4
Plasma Levels of Phospholipids in Patients With COVID-19; A Promising Simple Biochemical Parameter to Evaluate the Disease SeverityPreprint
Hussein, M. A., Ismail, N. E. M., Mohamed, A., Borik, R. M. A., Ali, A., & Mosaad, Y. O. (2020) · Research Square · doi:10.21203/rs.3.rs-57302/v1 · Cited by 4
Neurobiological, Behavioral, and Immune–Microbiome Interactions of Chronic Stress and Depression in Periodontitis and Peri-Implantitis: A Narrative Review with Clinical Management Insights
Marconcini, S., & Abbafati, E. (2022) · Asian Journal of Periodontics and Orthodontics · doi:10.51847/omhegqvurd · Cited by 3
Can Nutritional Supports Beneficial in Other Viral Diseases Be Favorable for COVID-19?
Zelka, F. Z., Kocatürk, R. R., Özcan, Ö. Ö., & Karahan, M. (2022) · Korean Journal of Family Medicine · doi:10.4082/kjfm.20.0134 · Cited by 3
Coronavirus disease 2019-related myocarditis genes contribute to ECMO prognosis
An, Y., Zhang, R., Feng, C., & Feng, J. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04032-5 · Cited by 3
Transcriptome Analysis of Lungs in a Mouse Model of Severe COVID-19
Cohen-Gihon, I., Israeli, O., Tidhar, A., Sapoznikov, A., Evgy, Y., Stein, D., Aftalion, M., Gur, D., Orr, I., Zvi, A., et al. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.848465 · Cited by 3
Immune Status of COVID-19 Patients with Reference to SARS and MERS
Karikalan, B., & Darnal, H. K. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.spl1.18 · Cited by 3
Judicious use of low-dosage corticosteroids for non-severe COVID-19: A case report
Zhang, J., Tian, Z., Feng, L., Yang, Z., Zou, B., Li, K., Zhang, Y., Wang, Y., Fleming, J., & Cui, W. (2021) · Open Medicine · doi:10.1515/med-2021-0250 · Cited by 3
Fundamental Basis of COVID-19 Pathogenesis
Bolevich, S., Litvitsky, P. F., Grachev, S. V., Vorobyev, S. I., Orlova, A. S., Fokina, M. A., Novikov, A. A., Bolevich, S. S., Mikhaleva, A. Y., Morozova, E. M., et al. (2020) · Serbian Journal of Experimental and Clinical Research · doi:10.2478/sjecr-2020-0029 · Cited by 3
Clinico-Epidemiological Laboratory Findings of COVID- 19 Positive Patients in a Hospital in Saudi Arabia
Elhag, W. I., Elamin, B. K., Idris, E. S., Elsheikh, A., Ghaleb, K. I., Fallatah, I., Hassan, D. A. E.-M., Elkhalifa, M., Moglad, E. H. O., & Eleragi, A. M. S. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s418629 · Cited by 2
H5 influenza haemagglutinin and cytokine profiles in cultured PBMCs from adults and children
Almansa, R., de Lejarazu, R. O., Jiménez‐Sousa, M. Á., Rico, L., Largo, E., Iglesias, V., Golvano, E., & Bermejo-Martín, J. F. (2011) · Inmunología · doi:10.1016/j.inmuno.2011.06.001 · Cited by 2
Viral Infection, Adaptive Immunity, and COPD
Almansa, R., & Bermejo-Martín, J. F. (2011) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0b013e3182217fcf · Cited by 2
The possible immunopathogenesis of SARS-Cov-2 Infection - A review of immune changes in patients with COVID-19
Fatima, S. H., Viquar, U., Ahmed, T., & Kazmi, M. H. (2020) · Indian Journal of Pathology and Oncology · doi:10.18231/j.ijpo.2020.105 · Cited by 2
Potential Effects of A Flavonoid, Hesperidin on SARS-CoV-2 Disease
Khazdair, M. R. (2021) · Advances in respiratory medicine · doi:10.5603/arm.a2021.0093 · Cited by 2
Exploring the scope of homoeopathy in combating the unfortunate consequences of post-COVID-19 survivors based on non-COVID conditions: a narrative review
Dixit, A., Giri, N., & Singh, S. H. (2021) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2021-0200 · Cited by 2
Immune responses to SARS-CoV-2 infection and COVID-19 vaccines
Sharma, B. R., & Veeranna, R. P. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00074 · Cited by 3
Cardiac injury and COVID-19: A Review on available present-day literature
Padma, V., Raja, R. B., & Nair, A. B. (2021) · Biomedicine · doi:10.51248/.v40i4.308 · Cited by 2
JAK Inhibitors as a Barrier to the Destructive Cytokine Storm in COVID-19
Saeedi‐Boroujeni, A., & Asadi-Samani, M. (2022) · Current Drug Research Reviews · doi:10.2174/2589977514666220304203816 · Cited by 2
Severe Acute Respiratory Syndrome Coronavirus 2 Dynamics of Human Infection: Molecular Biology, Virology, and Immunology
Mwapagha, L. M., Abugri, J., Kennedy, J., Zivuku, M., & Onywera, H. (2022) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2022.00111 · Cited by 2
The clinical rationale of Sacubitril/valsartan for therapeutic treatment in Sars-CoV-2Preprint
Ferrara, F., & Vitiello, A. (2020) · doi:10.22541/au.159493018.89024677 · Cited by 2
SARS-CoV-2 nucleocapsid protein dually regulates innate immune responsesPreprint
Zhao, Y., Sui, L., Wu, P., Wang, W., Tan, G., Wang, Z., Yu, Y., Hou, Z., Wang, G., & Liu, Q. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.17.431755 · Cited by 2
BATS AND CORONAVIRUSES
Beltz, L. A. (2017) · doi:10.1002/9781119150060.ch5 · Cited by 2
The unique ORF8 protein from SARS-CoV-2 binds to human dendritic cells and induces a hyper-inflammatory cytokine stormPreprint
Hamdorf, M., Imhof, T., Bailey-Elkin, B. A., Betz, J., Theobald, S. J., Simonis, A., Cristanziano, V. D., Gieselmann, L., Dewald, F., Lehmann, C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.06.494969 · Cited by 2
The Paradigm of Immune Dysregulation in COVID-19 InfectionPreprint
Sahoo, O. S., Pethusamy, K., Nayek, A., Minocha, R., Dhar, R., & Karmakar, S. (2023) · Preprints.org · doi:10.20944/preprints202307.1880.v1 · Cited by 1

Authors: Cameron, M. J., Bermejo-Martin, J. F., Danesh, A., Muller, M. P., & Kelvin, D. J.
Affiliations: University Health Network (CA)
Mount Sinai Hospital (CA)
Corresponding author: Kelvin, David J.
ORCID: Cameron, Mark J.
Danesh, Ali
Muller, Matthew P.
Kelvin, David J.
Venue: Virus Research
Publisher: Elsevier BV
Published: 2008-04
Volume: 133
Issue: 1
Pages: 13-19
ISSN: 0168-1702 (ISSN-L)
DOI: 10.1016/j.virusres.2007.02.014
PMC: PMC7114310
OpenAlex: W2076401107
Cited by: 391
References: 39
Citations by year: 2026: 1 · 2025: 6 · 2024: 17 · 2023: 21 · 2022: 65 · 2021: 95 · 2020: 126 · 2019: 3 · 2018: 2 · 2017: 6 · 2016: 5 · 2015: 1 · 2014: 6 · 2013: 2 · 2012: 9
FWCI: 4.44
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Virus Research (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Genome Canada
Ontario Genomics
Ontario Genomics Institute
Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords: SARS, SARS coronavirus, immunopathogenesis, cytokine storm, innate immunity, adaptive immunity, type I interferon, interferon-gamma, viral evasion, host immune response, inflammation
MeSH terms: Humans, Immunity, Innate, Models, Biological, Cytokines, Oligonucleotide Array Sequence Analysis, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus, Host-Pathogen Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Human immunopathogenesis of severe acute respiratory syndrome (SARS)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks